Interxion Holding N.V (INXN) Stock Value Rose While Js Capital Management Has Increased Position; Acadia Pharmaceuticals (Call) (ACAD) Shareholder Longwood Capital Partners Lowered Its Holding by $6.66 Million

January 17, 2018 - By Neil V. Hobbs

Longwood Capital Partners Llc decreased its stake in Acadia Pharmaceuticals Inc (Call) (ACAD) by 72% based on its latest 2017Q3 regulatory filing with the SEC. Longwood Capital Partners Llc sold 180,000 shares as the company’s stock declined 29.10% while stock markets rallied. The institutional investor held 70,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.64M, down from 250,000 at the end of the previous reported quarter. Longwood Capital Partners Llc who had been investing in Acadia Pharmaceuticals Inc (Call) for a number of months, seems to be less bullish one the $3.50 billion market cap company. The stock increased 0.18% or $0.05 during the last trading session, reaching $28.2. About 546,573 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since January 17, 2017 and is downtrending. It has underperformed by 31.89% the S&P500.

Jonathan Soros increased its stake in Interxion Holding N.V (INXN) by 13.33% based on its latest 2017Q3 regulatory filing with the SEC. Js Capital Management Llc bought 10,000 shares as the company’s stock rose 15.41% with the market. The hedge fund run by Jonathan Soros held 85,000 shares of the programming company at the end of 2017Q3, valued at $4.33 million, up from 75,000 at the end of the previous reported quarter. Js Capital Management Llc who had been investing in Interxion Holding N.V for a number of months, seems to be bullish on the $4.21B market cap company. The stock decreased 0.03% or $0.02 during the last trading session, reaching $58.96. About 181,452 shares traded. InterXion Holding N.V. (NYSE:INXN) has risen 30.50% since January 17, 2017 and is uptrending. It has outperformed by 13.80% the S&P500.

Longwood Capital Partners Llc, which manages about $558.01 million US Long portfolio, upped its stake in Viewray Inc by 645,596 shares to 1.33M shares, valued at $7.67 million in 2017Q3, according to the filing. It also increased its holding in Invitae Corp by 427,708 shares in the quarter, for a total of 528,000 shares, and has risen its stake in Lannet Inc (Put) (NYSE:LCI).

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 27. They expect $-0.58 earnings per share, up 10.77% or $0.07 from last year’s $-0.65 per share. After $-0.53 actual earnings per share reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 9.43% negative EPS growth.

Since August 9, 2017, it had 0 insider purchases, and 5 sales for $5.95 million activity. Another trade for 25,000 shares valued at $751,543 was sold by Brege Laura.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.04, from 1.05 in 2017Q2. It dived, as 25 investors sold ACAD shares while 58 reduced holdings. 32 funds opened positions while 52 raised stakes. 113.55 million shares or 1.98% less from 115.85 million shares in 2017Q2 were reported. 67,048 are owned by Royal National Bank Of Canada. Jpmorgan Chase And has invested 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Columbus Circle holds 0.03% or 53,984 shares. Bank & Trust Of Mellon Corp stated it has 452,696 shares or 0% of all its holdings. Fmr Ltd Liability Co stated it has 0.08% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Massachusetts Service Ma owns 179,536 shares. Baker Bros Ltd Partnership reported 7.89% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 23,626 were accumulated by Bnp Paribas Arbitrage Sa. Fred Alger holds 0.35% or 2.00 million shares. Hollencrest Securities Ltd Co accumulated 0.04% or 7,985 shares. 1,817 were accumulated by Qs Lc. Pub Employees Retirement Of Ohio has 37,950 shares for 0.01% of their portfolio. Goldman Sachs Gp Incorporated invested in 1.82M shares or 0.02% of the stock. Wells Fargo Mn holds 172,810 shares. Creative Planning reported 47,811 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: